Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
4.815
+0.125 (2.66%)
Jul 28, 2026, 1:43 PM EDT - Market open
Curis Employees
As of December 31, 2025, Curis had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 10 or -29.41% compared to the previous year.
Employees
24
Change (1Y)
-10
Growth (1Y)
-29.41%
Revenue / Employee
$294,292
Profits / Employee
-$881,875
Market Cap
9.38M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | -10 | -29.41% | 20 | 4 |
| Dec 31, 2024 | 34 | -15 | -30.61% | 33 | 1 |
| Dec 31, 2023 | 49 | -2 | -3.92% | 49 | 0 |
| Dec 31, 2022 | 51 | -9 | -15.00% | 51 | 0 |
| Dec 31, 2021 | 60 | 32 | 114.29% | 60 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Lunai Bioworks | 29 |
| BioCardia | 21 |
| Theriva Biologics | 16 |
| BioVie | 13 |
| Psyence Biomedical | 12 |
| Immuron | 7 |
| Quoin Pharmaceuticals | 6 |
CRIS News
- 4 days ago - Curis price target raised to $43 from $17 at H.C. Wainwright - TheFly
- 6 days ago - Curis Transcript: Study update - Transcripts
- 6 days ago - Curis Press release: Study update - Filings
- 6 days ago - Curis Slides: Study update - Filings
- 6 days ago - Curis to report clinical data in the TakeAim Lymphoma study - TheFly
- 6 days ago - Curis Announces Positive Emavusertib Update - PRNewsWire
- 13 days ago - Curis Slides: Corporate presentation - Filings
- 22 days ago - Curis consents first six patients in TakeAim CLL study - TheFly